Access to begin phase II trial of OraRinse for treatment and prevention of mucositis Jan. 31, 2000 No Comments
Schering-Plough seeks E.U. approval of Caelyx for treatment of advanced ovarian cancer Jan. 28, 2000 No Comments
RSS